CDC Warns of Surge in Rare Meningococcal Infections in the U.S.

The infections, mainly caused by a specific bacterial strain, are disproportionately affecting adults aged 30 to 60, particularly Black individuals and those with HIV.

The CDC has issued an urgent warning about a rise in rare meningococcal infections in the U.S., with 143 cases reported so far in 2024.
The infections are mainly caused by the Neisseria meningitidis serogroup Y strain, affecting adults aged 30 to 60 and disproportionately impacting Black people and those with HIV.
Symptoms of meningococcal disease include headache, stiff neck, vomiting, fever, nausea, and sensitivity to light, with severe cases potentially leading to death.
Healthcare providers are urged to increase awareness and monitoring for symptoms, and the public is advised to ensure vaccinations are up to date.
The CDC recommends the meningococcal vaccine for all 11- to 12-year-olds, with a booster dose at age 16, and additional doses for high-risk individuals.